The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

about

Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

P2860

Q58553604-9EE0E0AB-4E7E-4D3C-B73B-76F6C9C49F66 Q58738564-4109CA65-0B80-4BC3-8FB2-0718E8F531F3

P2860

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q42320961

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@en

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@nl

type

Item

label

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@en

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@nl

prefLabel

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@en

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@nl

P1476

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

@en

P2093

Olivier Cuvillier

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic challenges in renal cell carcinoma

Hypoxia-inducible factors in physiology and medicine

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor

Allosteric inhibition of hypoxia inducible factor-2 with small molecules

Structural integration in hypoxia-inducible factors

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene

P304

131-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2017.01.12

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Cuvillier

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28217462

http://www.w3.org/2001/XMLSchema#string

P932

5313304

http://www.w3.org/2001/XMLSchema#string

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

about

P2860

P2860

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932